Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...

A man living with advanced liver cancer has seen his tumour shrink by over half as “exciting” new clinical trials are ...

Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...

A mother of three who died days after receiving a liver cancer diagnosis is a tragically common case, a charity has said.

A groundbreaking cancer study led by Professor Tom Bird from the Cancer Research UK Scotland Institute has discovered a drug combination that ...

Hepatocellular carcinoma (HCC) is one of the deadliest malignant tumors in the world, and its incidence and mortality have ...

This study investigated the long-term prognosis and clinical course of patients who survived for more than 5 years after hepatocellular carcinoma (HCC) diagnosis.This retrospective cohort study used ...